A tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response

  1. James P Held
  2. Gaomin Feng
  3. Benjamin R Saunders
  4. Claudia V Pereria
  5. Kristopher Burkewitz
  6. Maulik R Patel  Is a corresponding author
  1. Department of Biological Sciences, Vanderbilt University, United States
  2. Department of Cell and Developmental Biology, Vanderbilt University, United States
  3. Diabetes Research and Training Center, Vanderbilt University School of Medicine, United States

Peer review process

This article was accepted for publication as part of eLife's original publishing model.

History

  1. Version of Record updated
  2. Version of Record published
  3. Accepted Manuscript published
  4. Accepted
  5. Received
  6. Preprint posted

Decision letter

  1. Xiaochen Wang
    Reviewing Editor; Institute of Biophysics Chinese Academy of Sciences, China
  2. David Ron
    Senior Editor; University of Cambridge, United Kingdom

Our editorial process produces two outputs: i) public reviews designed to be posted alongside the preprint for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Decision letter after peer review:

Thank you for submitting your article "A tRNA processing enzyme is a central regulator of the mitochondrial unfolded protein response" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by David Ron as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Essential revisions:

The following points (especially the major experiments) should be addressed to strengthen the conclusion that HOE-1 plays a specific role in the activation of mtUPR.

Major experiments:

1. The authors use the transcriptional reporter hsp-6::gfp as a mtUPR reporter.

However, a fluorescent signal requires not only transcription from the hsp-6 promoter (the parameter of interest) but also translation of the derived mRNA. As HOE-1 is a tRNA processing enzyme whose inactivation may affect protein synthesis, qRT-PCR analysis (or some alternative analytical strategy) should be performed to quantify the effects of HOE-1 inhibition on the mtUPR transcription response, independent of the translation of a reporter.

Several groups have shown that inhibition of S6 kinase inhibits mtUPR activation. As HOE-1 is presumably required for protein synthesis, perhaps the mechanism is related? Does inhibition of other genes affecting tRNA levels also impair mtUPR or is it specific to HOE-1?

2. It seems that the HOE-1 protein with a mitochondrial targeting sequence is

transcribed from the same gene as HOE-1 without the MTS. And there are separate transcriptional start sites for each mRNA/protein. Considering the number of claims related to subcellular localization of HOE-1, the authors must determine if transcription from either site is altered during mitochondrial stress. During mitochondrial stress, does the ratio of HOE-1 transcript change? For example, is the hoe-1 variant transcript lacking the MTS increased?

3. There is an important caveat regarding the interpretation of the hoe-1(∆NES) strain which causes mtUPR activation: It remains unclear if nuclear accumulation is an event driving mtUPR activation or if the activation reflects a different feature of the ∆NES mutation.

The authors suggest that mtUPR induction in hoe-1(∆NES) is a result of increased 3'-tRNA processing. Whether 3'-tRNA processing is elevated in hoe-1(∆NES) should be tested more directly. Is it possible to determine the tRNA species that are elevated in hoe-1(∆NES) strain by sequencing? Or that the authors can express hoe-1(∆NES) that lacks the enzymatic activity and see whether it can still activate mtUPR.

4. There is a concern In regards to the finding that hoe-1(ΔNES) mutant is sufficient to induce the nuclear accumulation of the ATFS-1 and the subsequent up-regulation of the mtUPR reporter gene: the authors did not rule out the possibility that mitochondrial protein homeostasis was already disrupted in hoe-1(ΔNES) mutants so that the mtUPR was induced. Does HOE-1∆NES cause mitochondrial dysfunction which increases mtUPR activation? The authors only showed that mitochondrial membrane potential was not changed in hoe-1(ΔNES) mutants. More characterization of mitochondrial function in hoe-1(ΔNES) mutants is required, such as OCR and mitochondrial morphology. It seems that hoe-1(ΔNES) mutants are smaller than wild-type animals. Alternatively, the ∆NES mutation could be combined with the ∆MTS mutation.

5. The authors generate a beautiful ATFS-1::mCherry fusion protein and

demonstrate that it accumulates within nuclei during mitochondrial stress. Why is the overall level of ATFS-1 dramatically increased in hoe-1(ΔNES) mutants (Figure 4a)? This is not consistent with only two-fold up-regulation of atfs-1 transcript levels. Does hoe-1 inhibition affect translation/synthesis of ATFS-1::mCherry or nuclear accumulation of ATFS-1::mCherry? Or, DVE-1?

The authors also need to show the ATFS-1::GFP expression pattern in the nuo-6 mutants as a control.

6. Regarding the specific involvement of HOE-1 in the regulation of mtUPR, since

tRNA processing, the tRNA exporter xpo-3, as well as the RNase P complex popl-1, are all general regulators for protein synthesis. How to explain the specific involvement of these regulators only in the regulation of the mtUPR? The authors mentioned that HOE-1 homolog ELAC2 is not only required for tRNA maturation but also essential for the formation of tRNA fragments, snoRNAs, and miRNAs, are these non-coding RNAs account for the activation of the mtUPR?

It is also confusing that HOE-1(∆NLS) mutants suppressed the mtUPR induction in nuo-6 mutants, however, xpo-3 which functions in the same pathway as HOE-1 in terms of tRNA processing and export did not suppress the mtUPR induction in nuo-6 mutants in Figure 6i and 6j.

Reviewer #2 (Recommendations for the authors):

It was reported that the epigenetic regulation of the UPRmt is in parallel with the ATFS-1 pathway (PMID: 27133168, PMID: 27133166). Whether these epigenetic factors are required for the induction of UPRmt in hoe-1(ΔNES) mutants. Similarly, whether HOE-1(NLS) suppressed the epigenetic changes or the accumulation of epigenetic factors (PMID: 27133166, PMID: 32789178, PMID: 32934238 ) in response to mitochondrial stresses.

https://doi.org/10.7554/eLife.71634.sa1

Author response

Essential revisions:

The following points (especially the major experiments) should be addressed to strengthen the conclusion that HOE-1 plays a specific role in the activation of mtUPR.

Major experiments:

1. The authors use the transcriptional reporter hsp-6::gfp as a mtUPR reporter.

However, a fluorescent signal requires not only transcription from the hsp-6 promoter (the parameter of interest) but also translation of the derived mRNA. As HOE-1 is a tRNA processing enzyme whose inactivation may affect protein synthesis, qRT-PCR analysis (or some alternative analytical strategy) should be performed to quantify the effects of HOE-1 inhibition on the mtUPR transcription response, independent of the translation of a reporter.

The reviewers raise an important point. To determine the effects of hoe-1 inhibition on the UPRmt transcriptional response independent of translation of the UPRmt reporter (hsp-6p::GFP) we performed droplet digital PCR to quantify transcripts of genes upregulated upon UPRmt activation (i.e. hsp-6 and cyp-14A4.1) in a wildtype and hoe-1(ΔNLS) background in the absence and presence of mitochondrial stress (control and spg-7 RNAi, respectively). We find that loss of nuclear HOE-1 results in attenuation of both hsp-6 and cyp-14A4.1 transcript levels in mitochondrial stress conditions (Figure 2I and Figure 2 —figure supplement 5A). This finding is consistent with the effect of loss of nuclear HOE-1 on UPRmt reporter induction and further suggests that nuclear HOE-1 is directly involved in UPRmt transcriptional response.

Several groups have shown that inhibition of S6 kinase inhibits mtUPR activation. As HOE-1 is presumably required for protein synthesis, perhaps the mechanism is related? Does inhibition of other genes affecting tRNA levels also impair mtUPR or is it specific to HOE-1?

The reviewers query whether inhibition of other genes affecting tRNA levels also impair UPRmt. To address this question we assessed UPRmt reporter activation in mitochondrial stressed animals when other tRNA processing genes are knocked-down. These include RNA polymerase III subunit, rpc-1 (Figure 6 —figure supplement 2C, 2D), RNAse P subunit, popl-1 (Figure 6C, 6D), and tRNA ligase, rtcb-1 (Figure 6 —figure supplement 3D, 3E). RNA polymerase III transcribes tRNAs, RNAse P processes 5’ ends of nascent tRNAs before they are processed at the 3’ end by HOE-1, and the tRNA ligase is involved in splicing of intron-containing tRNAs. Knockdown of rpc-1 did not significantly impact nuo-6(qm200) induced UPRmt. Knock-down of popl-1 and rtcb-1 partially attenuate UPRmt activation by nuo-6(qm200). These data suggest that the inhibition of UPRmt is not specific to hoe-1 loss-of-function and further strengthen the connection between tRNA biology and UPRmt.

Although not asked for directly, prompted by the reviewer suggestion, we also tested whether rpc1 and rtcb-1 knockdown impairs hoe-1(ΔNES)-induced UPRmt (we had already reported in the original manuscript that popl-1 RNAi suppresses hoe-1(ΔNES)-induced UPRmt). Like popl-1 RNAi, rpc-1 RNAi robustly attenuates hoe-1(ΔNES)-induced UPRmt (Figure 6 —figure supplement 2A, 2B) further suggesting that limiting the availability of tRNA substrates for HOE-1 to act on suppresses hoe-1(ΔNES)-induced UPRmt Knock-down of rtcb-1 also mildly attenuates hoe1(ΔNES)-induced UPRmt (Figure 6 —figure supplement 3A, 3B) suggesting that downstream rates of tRNA processing may also impact hoe-1(ΔNES)-induced UPRmt. These data provide further support for the role of tRNAs in inducing UPRmt.

The reviewers raise an interesting possibility that mTOR and HOE-1 mechanisms of UPRmt induction may be related or intertwined. Given the broad involvement of mTOR signaling in cellular processes we would need to fully investigate any potential connection between these pathways (i.e., direct interaction) in future work.

2. It seems that the HOE-1 protein with a mitochondrial targeting sequence is

transcribed from the same gene as HOE-1 without the MTS. And there are separate transcriptional start sites for each mRNA/protein. Considering the number of claims related to subcellular localization of HOE-1, the authors must determine if transcription from either site is altered during mitochondrial stress. During mitochondrial stress, does the ratio of HOE-1 transcript change? For example, is the hoe-1 variant transcript lacking the MTS increased?

We appreciate the reviewers’ suggestion to assess transcript dynamics of hoe-1. HOE-1 protein with and without a mitochondrial targeting sequence are indeed transcribed from the same gene locus. However, whether the two protein isoforms are independently transcribed is not clear. In fact, in human cell culture it has been shown that both mitochondrial and nuclear-targeted HOE1 are produced from the same transcript via alternative translation initiation (Rossmanith, PMID: 21559454). Thus, we first endeavored to determine the mode by which mitochondrial and nuclear HOE-1 are individually produced. We designed two sets of primers for measuring hoe-1 transcript levels. One set that amplifies only transcripts containing the sequence encoding the mitochondrial targeting sequence and one set that amplifies all HOE-1 transcripts (i.e., sequence that is found in both mitochondrial and nuclear isoforms). If the two isoforms are a result of independent transcription, we would expect the number of mitochondrial specific transcripts to be lower than total transcript levels. However, using droplet digital PCR, we find that the number of transcripts that include a mitochondrial targeting sequence were nearly identical to the number of total hoe1 transcripts (Figure 8 —figure supplement 1A). This finding suggests, that like in higher eukaryotes, HOE-1 is dual-targeted via differential translation of a single transcript.

Given the above finding, we next endeavored to determine if hoe-1 transcript levels are altered upon mitochondrial stress. We find that hoe-1 transcript levels are mildly elevated under conditions of mitochondrial stress (i.e., nuo-6(qm200) worms) relative to wildtype when measured by ddPCR using both sets of aforementioned primers (Figure 8 —figure supplement 1B, 1C). These findings are consistent with our HOE-1 protein level analysis and support our finding that nuclear HOE-1 levels are elevated upon mitochondrial stress.

3. There is an important caveat regarding the interpretation of the hoe-1(∆NES) strain which causes mtUPR activation: It remains unclear if nuclear accumulation is an event driving mtUPR activation or if the activation reflects a different feature of the ∆NES mutation.

The authors suggest that mtUPR induction in hoe-1(∆NES) is a result of increased 3'-tRNA processing. Whether 3'-tRNA processing is elevated in hoe-1(∆NES) should be tested more directly. Is it possible to determine the tRNA species that are elevated in hoe-1(∆NES) strain by sequencing? Or that the authors can express hoe-1(∆NES) that lacks the enzymatic activity and see whether it can still activate mtUPR.

The reviewers raise an important point regarding the functional nature of the hoe-1(ΔNES) mutant that we generated and used in the manuscript. To validate the function of the hoe-1(ΔNES) allele we conducted three complimentary experiments. First, as suggested, we created a catalyticallydead hoe-1(ΔNES) allele by introducing a point mutation (D624A) in hoe-1 that ablates zinc binding. The endonuclease activity of HOE-1 is dependent upon zinc binding as it is a zinc phosphodiesterase. Homozygous hoe-1(D624A+ΔNES) animals have the same arrest phenotype as hoe-1 null animals. Given that UPRmt is not activated in hoe-1(ΔNES) animals until late in development we needed to be able to assess the impact of the D624A mutation later in development. To overcome this constraint we established hoe-1(ΔNES)/hoe-1(D624A+ΔNES) trans-heterozygous animals that expressed the UPRmt reporter hsp-6p::GFP. These animals were able to grow to adulthood and thus we could assess impact on UPRmt activation. hoe1(ΔNES)/hoe-1(D624A+ΔNES) trans-heterozygous animals had markedly diminished UPRmt activation relative to homozygous hoe-1(ΔNES) animals (Figure 6 —figure supplement 1A, 1B) suggesting that the ability of hoe-1(ΔNES) to activate UPRmt requires the RNA processing function of HOE-1.

Secondly, for hoe-1(ΔNES) to facilitate increased 3’-tRNA processing this would likely require there to be elevated nuclear HOE-1 levels in hoe-1(ΔNES) animals. To assess this we generated a C-terminally GFP-tagged hoe-1(ΔNES) allele hoe-1(ΔNES::GFP) and compared it’s subcellular expression to wildtype hoe-1::GFP. Based on high resolution imaging and its quantification, there is elevated HOE-1::GFP signal in nuclei of the hoe-1(ΔNES) background relative to wildtype (Figure 3 —figure supplement 1B, Figure 2 —figure supplement 4B, 4C). This finding is consistent with our hypothesis that there is increased 3’-tRNA processing in hoe-1(ΔNES) animals.

Third, and finally, if elevated nuclear HOE-1 levels are responsible for UPRmt activation we reasoned that ablating HOE-1 nuclear localization in hoe-1(ΔNES) animals (hoe-1(ΔNLS+ΔNES)) should inactivate hoe-1(ΔNES)-induced UPRmt. Indeed we found that compromising HOE-1 nuclear localization was sufficient to completely attenuate UPRmt induced by hoe-1(ΔNES) (Figure 3 —figure supplement 3A, 3B). This finding strongly suggests that HOE-1 is required in the nucleus to activate UPRmt.

Combined, these experiments suggest that UPRmt in hoe-1(ΔNES) animals is induced by increased 3’-tRNA processing that is a result of elevated nuclear levels of HOE-1.

4. There is a concern In regards to the finding that hoe-1(ΔNES) mutant is sufficient to induce the nuclear accumulation of the ATFS-1 and the subsequent up-regulation of the mtUPR reporter gene: the authors did not rule out the possibility that mitochondrial protein homeostasis was already disrupted in hoe-1(ΔNES) mutants so that the mtUPR was induced. Does HOE-1∆NES cause mitochondrial dysfunction which increases mtUPR activation? The authors only showed that mitochondrial membrane potential was not changed in hoe-1(ΔNES) mutants. More characterization of mitochondrial function in hoe-1(ΔNES) mutants is required, such as OCR and mitochondrial morphology. It seems that hoe-1(ΔNES) mutants are smaller than wild-type animals. Alternatively, the ∆NES mutation could be combined with the ∆MTS mutation.

We thank the reviewers for making this important suggestion to more thoroughly investigate the relationship between UPRmt and mitochondrial function in hoe-1(ΔNES) animals. The experiments we conducted in response to these suggestions proved to be very informative. Compromised mitochondrial membrane potential has been shown to be the driving factor for UPRmt activation as decreased membrane potential impairs mitochondrial import of proteins with weakly charged mitochondrial targeting sequences including ATFS-1 (Rolland et al., PMID: 31412237, Shpilka et al., PMID: 33473112). In the original draft of the manuscript, we had measured membrane potential in L4 stage animals and had not observed any differences between wildtype and hoe1(ΔNES) animals. However, as the UPRmt is most robustly induced in 2-day old adult hoe1(ΔNES) animals, we reassessed membrane potential at this later stage. Furthermore, in collaboration with the Burkewitz Lab, this measurement was done using high resolution microscopy as opposed to whole animal imaging. We conducted TMRE staining on adult hoe1(ΔNES) and wildtype animals and found that mitochondrial membrane potential is significantly reduced in hoe-1(ΔNES) relative to wildtype (Figure 4A, 4B). Thus, these data are consistent with the reviewers’ surmise that there may be mitochondrial dysfunction in hoe-1(ΔNES) animals. Interestingly, hoe-1(ΔNLS) animals also show a similarly drastic decline in mitochondrial membrane potential (Figure 4A, 4B), despite the fact that UPRmt is attenuated in this background. Thus, while there is a correlation between decreased membrane potential and UPRmt induction in hoe-1(ΔNES) animals, it is difficult to infer causality between the two.

UPRmt induction has been reported to cause a decrease in mitochondrial membrane potential. Therefore, we wondered whether UPRmt causes decline in mitochondrial membrane potential in hoe-1(ΔNES) animals. To test for this possibility, we measured mitochondrial membrane potential using TMRE in hoe-1(ΔNES) on atfs-1 RNAi. Loss of atfs-1 did not rescue membrane potential in hoe-1(ΔNES) background. Based on these data, we conclude in the manuscript that hoe-1(ΔNES) directly causes a decrease in mitochondrial membrane potential independent of UPRmt.

In addition, we took the reviewers’ suggestion of creating a hoe-1(ΔMTS+ΔNES) mutant to address whether hoe-1(ΔNES) may be having a compromising effect directly in the mitochondria. If hoe-1(ΔNES) is causing UPRmt by acting in the mitochondria, then impairing its mitochondrial localization should attenuate hoe-1(ΔNES)-induced UPRmt. If instead, as we hypothesized, hoe1(ΔNES) activates UPRmt through its nuclear role, then compromising mitochondrial localization of HOE-1 should not attenuate hoe-1(ΔNES)-induced UPRmt. We found that hoe-1(ΔMTS+ΔNES) animals have higher UPRmt activation than hoe-1(ΔNES) alone (Figure 3 —figure supplement 4A, 4B). This is consistent with HOE-1 activating UPRmt via increased nuclear accumulation and rules out the possibility that mitochondrial localized HOE-1 induces UPRmt in hoe-1(ΔNES) animals.

5. The authors generate a beautiful ATFS-1::mCherry fusion protein and

demonstrate that it accumulates within nuclei during mitochondrial stress. Why is the overall level of ATFS-1 dramatically increased in hoe-1(ΔNES) mutants (Figure 4a)? This is not consistent with only two-fold up-regulation of atfs-1 transcript levels. Does hoe-1 inhibition affect translation/synthesis of ATFS-1::mCherry or nuclear accumulation of ATFS-1::mCherry? Or, DVE-1?

The authors also need to show the ATFS-1::GFP expression pattern in the nuo-6 mutants as a control.

To more thoroughly investigate ATFS-1 levels across backgrounds, with the help from the Burkewitz Lab, we conducted the ATFS-1::mCherry imaging experiments at high resolution using confocal microscopy as opposed to our original imaging which was done on a Nikon Ti-E Fluorescence Motorized DIC Polarization Microscope. In addition to wildtype and hoe-1(ΔNES) animals, we also imaged ATFS-1::mCherry in nuo-6(qm200) animals as a positive control, as suggested by the reviewers. High resolution microscopy of ATFS-1::mCherry confirmed our previous findings that nuclear ATFS-1 levels are elevated in hoe-1(ΔNES) (Figure 5A, 5B). Importantly, nuclear ATFS-1 levels were also elevated under mitochondrial stress (i.e. nuo6(qm200) animals) as expected (Nargund et al., PMID: 22700657). We also quantified total cellular and extranuclear ATFS-1::mCherry fluorescence levels to address the reviewers’ question regarding the impact of hoe-1(ΔNES) on ATFS-1 translation/synthesis. hoe-1(ΔNES) animals do not exhibit elevated total or extranuclear ATFS-1::mCherry levels (Figure 5C and Figure 5 —figure supplement 1A). These data suggest that hoe-1(ΔNES) results in elevated nuclear localization but not increased ATFS-1 protein levels.

Similarly, to address the impact of hoe-1(ΔNES) on DVE-1 translation/synthesis level we conducted a western blot for DVE-1::GFP in a wildtype vs hoe-1(ΔNES) background. DVE-1 levels are not significantly different between wildtype and hoe-1(ΔNES) (Figure 5G, 5H, Figure 5 – source data 1) suggesting that hoe-1(ΔNES) triggers nuclear accumulation of DVE-1 as opposed to upregulating total DVE-1 protein levels.

6. Regarding the specific involvement of HOE-1 in the regulation of mtUPR, since

tRNA processing, the tRNA exporter xpo-3, as well as the RNase P complex popl-1, are all general regulators for protein synthesis. How to explain the specific involvement of these regulators only in the regulation of the mtUPR? The authors mentioned that HOE-1 homolog ELAC2 is not only required for tRNA maturation but also essential for the formation of tRNA fragments, snoRNAs, and miRNAs, are these non-coding RNAs account for the activation of the mtUPR? It is also confusing that HOE-1(∆NLS) mutants suppressed the mtUPR induction in nuo-6 mutants, however, xpo-3 which functions in the same pathway as HOE-1 in terms of tRNA processing and export did not suppress the mtUPR induction in nuo-6 mutants in Figure 6i and 6j.

We appreciate these reviewer comments. While indeed xpo-3 and popl-1 should be required for protein synthesis it is clear from our results that modulating their activity can specifically impact UPRmt. While surprising, these data support the idea that in addition to their role in protein synthesis more generally, tRNAs (or other putative HOE-1-processed RNAs) play a specific signaling role in modulating UPRmt. This idea explains how RNAi against essential tRNA processing machinery, while strong enough to compromise UPRmt activation, is not strong enough to significantly impact protein synthesis. Indeed this reasoning is supported by the fact that animals on xpo-3 and popl-1 RNAi grow to adulthood.

Orthologs of HOE-1 have been reported to be capable of processing other RNA species. If those species are involved in UPRmt regulation they would need to be transported by tRNA exportin (xpo-3)—while such xpo-3 dependent transport of non-tRNAs has not been shown to date, it is plausible. We have addressed this possibility in the discussion (manuscript page 17, lines 8-10) and look forward to identifying the causal RNA in future studies.

We agree that the differential impact of xpo-3 RNAi on hoe-1(ΔNES)- and nuo-6(qm200)-induced UPRmt is interesting. One reasonable hypothesis to explain this data is that while HOE-1 processed tRNAs play a role in activating UPRmt in response to mitochondrial stress, ATFS-1 is also capable of activating UPRmt directly. In contrast, HOE-1 processed tRNAs are presumably solely responsible for UPRmt activation in hoe-1(ΔNES) animals and hence completely dependent on their exporter XPO-3. We hope to formally test this hypothesis once we identify the causal RNA species in the future.

Reviewer #2 (Recommendations for the authors):

It was reported that the epigenetic regulation of the UPRmt is in parallel with the ATFS-1 pathway (PMID: 27133168, PMID: 27133166). Whether these epigenetic factors are required for the induction of UPRmt in hoe-1(ΔNES) mutants. Similarly, whether HOE-1(NLS) suppressed the epigenetic changes or the accumulation of epigenetic factors (PMID: 27133166, PMID: 32789178, PMID: 32934238 ) in response to mitochondrial stresses.

We thank the reviewer for this suggestion. We agree that the involvement of epigenetic regulation is a plausible and intriguing possibility. To thoroughly assess such involvement, we feel, is outside of the scope of the current manuscript. We look forward to addressing this in future studies.

https://doi.org/10.7554/eLife.71634.sa2

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. James P Held
  2. Gaomin Feng
  3. Benjamin R Saunders
  4. Claudia V Pereria
  5. Kristopher Burkewitz
  6. Maulik R Patel
(2022)
A tRNA processing enzyme is a key regulator of the mitochondrial unfolded protein response
eLife 11:e71634.
https://doi.org/10.7554/eLife.71634

Share this article

https://doi.org/10.7554/eLife.71634